Latest Market Dilution News

Radiopharm Theranostics (ASX:RAD) is raising up to $18.5 million via a two-tranche placement, a share purchase plan, and a concurrent US offering, aiming to bolster its clinical programs and working capital.

Adherium Limited has announced an accelerated non-renounceable entitlement offer to raise approximately A$4 million, issuing new shares and options to fund expansion and product development. The offer includes a Top-Up Facility and is partially underwritten, signaling a strategic push to scale its respiratory monitoring technology.